INKT SEC Filings: 8-K, 10-Q, S-3 & 424B

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 13, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 15, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Mar 31, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 14, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 14, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 15, 2025

News

TYPE

HEADLINE

FILED AT

Prospectus

TYPE

HEADLINE

FILED AT

424B5

August 2025 ATM | Offering amount: $36,585,515 | Amount sold to date: $13,414,485 | Float: 1,539,804

Aug 22, 2025

424B5

July 2025 ATM | Amount sold to date: $0 | Float: 1,011,500

Jul 15, 2025

424B3

UPDATED | SHARE RESALE REGISTRATION | Shares amount: 4,640,000

Aug 16, 2024

424B4

OFFERING | Shares amount: 3,333,334 | Share price: $12.00 | Offering amount: $40,000,008.00

Oct 15, 2021

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Aug 13, 2026

S-3/A

SHARE RESALE REGISTRATION | Offering amount: $150,000,000 | Float: 2,159,494 | Amount sold to date: $163,660

Dec 10, 2025

S-3

November 2025 SHELF & ATM | Float: 2,149,184 | Amount sold to date: $163,660

Nov 7, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Aug 14, 2025

S-3

SHELF EFFECTIVE

Aug 13, 2024

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Aug 13, 2024

Proxies

TYPE

HEADLINE

FILED AT

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 30, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 30, 2025

PRE 14A

Form PRE 14A - Other preliminary proxy statements

Apr 18, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Dec 20, 2024

PRE 14A

Form PRE 14A - Other preliminary proxy statements

Dec 6, 2024

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 29, 2024

Ownerships

TYPE

HEADLINE

FILED AT

Buell Jennifer (Reporting)

Oct 14, 2026

144

Form 144 - Report of proposed sale of securities

Oct 13, 2026

WIINBERG ULF (Reporting)

Sep 2, 2026

Holcomb John Bradley (Reporting)

Sep 2, 2026

Behner Peter (Reporting)

Sep 2, 2026

Ryan Barbara (Reporting)

Sep 2, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Dec 12, 2025

CORRESP

Form CORRESP - Correspondence

Dec 10, 2025

EFFECT

Form EFFECT - Notice of Effectiveness

Aug 19, 2024

CORRESP

Form CORRESP - Correspondence

Aug 15, 2024

LETTER

Form UPLOAD - SEC-generated letter

Aug 15, 2024

EFFECT

Form EFFECT - Notice of Effectiveness

Nov 9, 2022

MiNK Therapeutics, Inc. INKT · SEC Filings